Response to Matters Arising about the etiology of ventilator-associated pneumonia in the European POS-VAP cohort

Category	Detail
Condition	Ventilator-Associated Pneumonia (VAP)
Key Mechanisms	Microbial colonization and infection by Gram-negative and Gram-positive pathogens.
Target Population	ICU patients undergoing invasive mechanical ventilation.
Care Setting	Intensive Care Units (ICUs)

Most VAP cases are caused by Gram-negative pathogens, with S. aureus being the most common Gram-positive pathogen.
In the POS-VAP cohort, S. aureus accounted for 26.2% of microbiologically evaluable VAP cases.
The distribution of pathogens varies by geographic region and patient case mix.
Early VAP is more frequently associated with S. aureus, while late VAP shows a higher proportion of P. aeruginosa.
Microbiological confirmation of VAP was available for 60.7% of cases in the POS-VAP study.

VAP diagnosis relies on chest imaging suggestive of pneumonia and clinical signs in patients under IMV for at least 48 hours.

Microbiological testing should be performed using blood and/or respiratory samples.

Higher risk of VAP associated with comorbidities such as diabetes and conditions like stroke and trauma.

Predominantly male ICU patients around 60 years of age with high comorbidity rates.

Pathogen distribution and treatment may vary based on geographic location and patient demographics.

Consider country-specific epidemiology when assessing VAP aetiology.
Utilize stringent criteria to avoid double counting of VAP episodes.
Encourage microbiological confirmation of VAP through appropriate sampling methods.

Clinical Scorecard: Clarification on Issues Raised Regarding the Causes of Ventilator-Associated Pneumonia in the European POS-VAP Study Cohort